Adcetris
Oncology therapy developed through rigorous clinical research
Healthcare & MedicalFree
About Adcetris
Adcetris (brentuximab vedotin) from Seagen/Pfizer was one of the first approved ADCs targeting CD30 in lymphomas. It demonstrates durable responses but faces resistance issues common to single-target ADCs. Valink Therapeutics positions its bispecific V-Gate candidates as potential solutions for similar resistance mechanisms through multi-antigen logic in solid tumours where Adcetris is not indicated.
What Adcetris does
Pfizer is one of the world's premier biopharmaceutical companies focused on oncology among other areas. Their oncology efforts aim to transform cancer treatment across the landscape to improve lives of patients worldwide. Every product results from extensive lab tests and clinical trials before reaching patients.
Key features
- Oncology focus
- Extensive clinical trials
- Global supply commitment
- Patient assistance programs
Pricing
Free
Similar Products
Therapy for Black Girls
Culturally responsive mental health resources and therapist directory for Black women and girls.
Healthcare & MedicalFree
Manhattan Mental Health Counseling
NYC-based online therapy with licensed therapists accepting insurance for anxiety, trauma, and life transitions.
Healthcare & MedicalFree
T
Teen Counseling
Online therapy for teens and parents via text, phone, and video from licensed therapists.
Healthcare & MedicalFree